COVID-19 and immunosuppressants: An opinion pool of practicing dermatologists of India

Dermatol Ther. 2020 Nov;33(6):e14036. doi: 10.1111/dth.14036. Epub 2020 Aug 14.

Authors

Arunima Ray¹, Ipsita Debata¹, Ishan Agrawal¹, Maitreyee Panda¹

Affiliation

¹ Department of Dermatology, IMS and SUM Hospital, Bhubaneswar, India.

No abstract available

Publication types

Letter

MeSH terms

Attitude of Health Personnel
COVID-19 / diagnosis
COVID-19 / immunology
COVID-19 / virology*
Dermatologic Agents / administration & dosage*
Dermatologic Agents / adverse effects
Dermatologists / trends*
Health Care Surveys
Health Knowledge, Attitudes, Practice
Host-Pathogen Interactions
Humans
Immunocompromised Host
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
India
Practice Patterns, Physicians' / trends*
Risk Assessment
Risk Factors
SARS-CoV-2 / immunology
SARS-CoV-2 / pathogenicity*
Skin Diseases / diagnosis
Skin Diseases / drug therapy*
Skin Diseases / immunology

Substances

Dermatologic Agents
Immunosuppressive Agents